SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Dr Reddys Laboratories Ltd – ‘6-K’ for 1/8/16

On:  Friday, 1/8/16, at 11:20am ET   ·   For:  1/8/16   ·   Accession #:  1193125-16-424346   ·   File #:  1-15182

Previous ‘6-K’:  ‘6-K’ on / for 12/10/15   ·   Next:  ‘6-K’ on 2/9/16 for 12/31/15   ·   Latest:  ‘6-K’ on / for 4/18/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 1/08/16  Dr Reddys Laboratories Ltd        6-K         1/08/16    4:73K                                    RR Donnelley/FA

Report by a Foreign Private Issuer   —   Form 6-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 6-K         Report by a Foreign Private Issuer                  HTML     12K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML     10K 
 3: EX-99.2     Miscellaneous Exhibit                               HTML     11K 
 4: EX-99.3     Miscellaneous Exhibit                               HTML      9K 


6-K   —   Report by a Foreign Private Issuer


This is an HTML Document rendered as filed.  [ Alternative Formats ]



  Form 6-K  

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

Form 6-K

 

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13A-16 OR 15D-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

December 2015

Commission File Number 1-15182

 

 

DR. REDDY’S LABORATORIES LIMITED

(Translation of registrant’s name into English)

 

 

8-2-337, Road No. 3, Banjara Hills

Hyderabad, Telangana 500 034, India

+91-40-49002900

(Address of principal executive office)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F  x            Form 40-F  ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ¨

Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ¨

Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes  ¨            No   x

If “Yes” is marked, indicate below the file number assigned to registrant in connection with Rule 12g3-2(b): 82-            .

 

 

 


EXHIBITS

 

Exhibit

Number

  

Description of Exhibits

99.1    Press Release, “Dr. Reddy’s signs MoU with Life Sciences Sector Skill Development Council and Vishnu Institute of Pharmaceutical Education and Research to Strengthen the Skilled Labour Pool in the Life Science Industry,” December 7, 2015.
99.2   

Press Release, “Dr. Reddy’s promotes access to Community Health in Vizianagaram District Community Health Intervention Program (CHIP) to benefit over 70,000 people across 50 villages of Puspatirega Mandal,” December 18, 2015.

99.3    Press Release, “Dr. Reddy’s announces the relaunch of Esomeprazole Magnesium Delayed-Release Capsules, USP,” December 30, 2015.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

   

DR. REDDY’S LABORATORIES LIMITED

(Registrant)

Date: January 8, 2016     By:  

/s/ Sandeep Poddar

    Name:   Sandeep Poddar
    Title:   Company Secretary

Dates Referenced Herein

This ‘6-K’ Filing    Date    Other Filings
Filed on / For Period End:1/8/16None on these Dates
12/30/15
12/18/15
12/7/15
 List all Filings 
Top
Filing Submission 0001193125-16-424346   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Apr. 19, 3:03:22.2am ET